News & Views

From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.

Read more
Show me:
Showing 800 articles
Image
News placeholder image
27.04.2021

DUKPC research highlights: Day 6

As we kicked off week 2 of our professional conference (DUKPC), scientists brought us trailblazing update...
Image
News placeholder image
26.04.2021

DUKPC research highlights: Day 5

Week one of our professional conference (DUKPC) wrapped up with important research highlighting inequalit...
Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk